Selinexor, High-dose Methotrexate, and Rituximab Combined With Radiotherapy for Newly Diagnosed, Transplant-ineligible Patients With Central Nervous System Lymphoma: An Open-label, Single-arm, Multicenter Phase II Study

​ Conditions: Lymphomas

Interventions: Drug: Selinexor + High-dose Methotrexate + Rituximab + WBRT

Sponsors: Second Affiliated Hospital of Soochow University

Recruiting Conditions: Lymphomas
Interventions: Drug: Selinexor + High-dose Methotrexate + Rituximab + WBRT
Sponsors: Second Affiliated Hospital of Soochow University
Recruiting